Q1 2026 · 13F-HR
Empery Asset Management, LPholdings as filed
Filed 2026-05-08 · accession 0000902664-26-002332
The Brief · Empery Asset Management, LP · Q1 2026
AI · grounded in 13F
Empery Asset Management, LP closed its position in Immuneering Corp IMRX, reducing exposure by $17.6M. The fund also exited positions in Aduro Clean Technologies Inc ADUR for $5.9M and Eos Energy Enterprises Inc EOSE for $2.8M. On the buy side, the fund established a new position in VENU HLDG CORP VENU worth $3.3M. Other new entries include U S ENERGY CORP DEL USEG at $1.6M and SCYNEXIS INC SCYX at $1.6M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 98420X202 | XFOR | X4 PHARMACEUTICALS INC | $36.9M | 44.5% | 8,944,118 | Common | SOLE |
| 92864V608 | EMPD | EMPERY DIGITAL INC | $12.4M | 14.9% | 2,930,345 | Common | SOLE |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $10.8M | 13.0% | 1,968,879 | Common | SOLE |
| Y3894J187 | IMPP | IMPERIAL PETE INC | $3.8M | 4.52% | 877,645 | Common | SOLE |
| 92333E104 | VENU | VENU HLDG CORP | $3.3M | 4.02% | 1,007,729 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $3.0M | 3.58% | 4,286,933 | Common | SOLE |
| 911805307 | USEG | U S ENERGY CORP DEL | $1.7M | 2.04% | 1,917,844 | Common | SOLE |
| 811292200 | SCYX | SCYNEXIS INC | $1.7M | 2.04% | 1,847,826 | Common | SOLE |
| 23257B305 | CYN | CYNGN INC | $1.6M | 1.92% | 957,784 | Common | SOLE |
| 47010E108 | JAGU | JAGUAR URANIUM CORP | $1.3M | 1.61% | 487,500 | Common | SOLE |
| 80401L803 | MSLE | SATELLOS BIOSCIENCE INC | $1.3M | 1.56% | 230,100 | Common | SOLE |
| G2662B103 | CRML | CRITICAL METALS CORP | $1.0M | 1.26% | 132,039 | Common | SOLE |
| 91688R108 | URG | UR-ENERGY INC | $924,003 | 1.11% | 620,136 | Common | SOLE |
| 74346M505 | PMN | PROMIS NEUROSCIENCES INC | $766,483 | 0.92% | 60,353 | Common | SOLE |
| 86804F509 | SLE | SUPER LEAGUE ENTERPRISE INC | $491,793 | 0.59% | 132,917 | Common | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $441,030 | 0.53% | 590,481 | Common | SOLE |
| 08205P209 | BNTC | BENITEC BIOPHARMA INC | $324,186 | 0.39% | 30,440 | Common | SOLE |
| 107930125 | BCTXL | BRIACELL THERAPEUTICS CORP | $309,030 | 0.37% | 300,000 | Common | SOLE |
| G6S34K113 | ABTS | ABITS GROUP INC | $266,052 | 0.32% | 172,761 | Common | SOLE |
| M7S13T102 | PRZO | PARAZERO TECHNOLOGIES LTD | $217,575 | 0.26% | 282,199 | Common | SOLE |
| M7071P109 | NSRX | NASUS PHARMA LTD | $101,683 | 0.12% | 45,803 | Common | SOLE |
| 107930117 | BCTXZ | BRIACELL THERAPEUTICS CORP | $93,324 | 0.11% | 666,600 | Common | SOLE |
| 67092M125 | NTRBW | NUTRIBAND INC | $45,044 | 0.05% | 40,218 | Common | SOLE |
| M68057112 | MTEKW | MARIS TECH LTD | $44,938 | 0.05% | 297,600 | Common | SOLE |
| G7490F127 | RTACW | RENATUS TACTICAL ACQUIS | $23,005 | 0.03% | 50,000 | Common | SOLE |
| M74240116 | NRSNW | NEUROSENSE THERAPEUTICS LTD | $20,080 | 0.02% | 100,402 | Common | SOLE |
| 84757T113 | MDAIW | SPECTRAL AI INC | $18,665 | 0.02% | 33,336 | Common | SOLE |
| 86887P119 | BNCWW | CEA INDUSTRIES INC | $15,300 | 0.02% | 500,000 | Common | SOLE |
| 58471K111 | MDCXW | MEDICUS PHARMA LTD | $11,494 | 0.01% | 12,100 | Common | SOLE |
| M61472110 | NEXRW | NEXERA TECHNOLOGIES LTD | $6,130 | 0.01% | 360,577 | Common | SOLE |
| 65344E115 | NXGLW | NEXGEL INC | $5,391 | 0.01% | 90,000 | Common | SOLE |
| G3302D111 | FGIWW | FGI INDUSTRIES LTD | $2,694 | 0.00% | 83,928 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.